alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit
32.1





CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report
of Equicap, Inc. (the “Company”) on Form 10-Q for the period ended March 31,
2009 as filed with the Securities and Exchange Commission on the date hereof
(the “Report”), the undersigned, Peter Wang, President and David Ming He, Chief
Financial Officer, each certify, pursuant to 18 U.S.C. ss. 1350, as adopted
pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the
undersigned’s knowledge:





(1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





/s/
      Peter WangPeter
      WangPresidentPrincipal
      Executive OfficerMay
      11, 2009/s/
      David Ming HeDavid
      Ming HeChief
      Financial OfficerPrincipal
      Financial OfficerMay
      11, 2009




A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.





The
foregoing certification is being furnished with the Company’s Report pursuant to
18 U.S.C. Section 1350. It is not being filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, and it is not to be incorporated by
reference into any filing of the Company, whether made before or after the date
hereof, regardless of any general incorporation language in such
filing.
# Official Journal C 93E/2008

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 93E |
| | |
| English edition | Information and Notices | Volume 5115 April 2008 |

ISSN 1725-2423

Official Journal

of the European Union

C 93E

English edition

Information and Notices

Volume 5115 April 2008

---

| Notice No | Contents | page |
| --- | --- | --- |
| | III   Preparatory Acts |
| | COUNCIL |
| 2008/C 093E/01 | Common Position (EC) No 5/2008 of 3 March 2008 adopted by the Council, acting in accordance with the procedure referred to in Article 251 of the Treaty establishing the European Community, with a view to the adoption of a Regulation of the European Parliament and of the Council amending Regulation (EC) No 881/2004 establishing a European Railway Agency (Agency Regulation) (1) | 1 |

Notice No

Contents

page

III   Preparatory Acts

COUNCIL

2008/C 093E/01

Common Position (EC) No 5/2008 of 3 March 2008 adopted by the Council, acting in accordance with the procedure referred to in Article 251 of the Treaty establishing the European Community, with a view to the adoption of a Regulation of the European Parliament and of the Council amending Regulation (EC) No 881/2004 establishing a European Railway Agency (Agency Regulation) (1)

1

---

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | |
| --- | --- |

EN
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

UNITED STATES OF AMERICA,

Plaintiff

- Appellee,

v.

KIMBERLY CRAWFORD,

Defendant

- Appellant. No. 14

- 10205

D.C. No. 2:10

- cr

- 00547

- RLH

MEMORANDUM *

Appeal from the United States District Court

for the District of Nevada

Roger L. Hunt, District Judge, Presiding

Submitted January 21, 2015 **

Before: CANBY, GOULD, and N

. R

. SMITH, Circuit Judges.

Kimberly Crawford appeals from the district court’ s judgment and challenges

the 11

- month s entence imposed upon revocation of supervised release. We have

jurisdiction under 28 U.S.C. § 1291, and we affirm.

Crawford contends that the district court procedurally erred by failing to

* This disposition is not appropriate for publication and is not precedent

except as provided by 9th Cir. R. 36

- 3.

** The panel unanimously concludes this case is suitable for decision

without oral argument. See Fed. R. App. P. 34(a)(2). 

# FILED

JAN 27 2015

MOLLY C. DWYER, CLER K

U.S. COURT OF APPEAL S2 14

- 10205

explain adequately its reasons for rejecting her sentencing argument s

. We review

for plain error, see United States v. Miqbel , 444 F.3d 1173, 1176 (9th Cir. 2006), an d

find none. The record reflects that the court considered Crawford’s arguments and

sufficiently explained the sentence. See United States v. Carty , 520 F.3d 984, 992

(9th Cir. 2008) (en banc).

Crawford next contends that her senten ce is substantively unreasonable in

light of her history of addiction and her rehabilitative efforts . The district court did

not abuse its discretion in imposing Crawford’s sentence

. See Gall v. United States

,

552 U.S. 38, 51 (2007). The sentence is substantively reaso nable in light of the 18

U.S.C. § 3583(e) sentencing factors and the totality of the circumstances, including

Crawford’s multiple violations of supervised release and the need to afford adequate

deterrence

. See Gall , 552 U.S. at 51

.

AFFIRMED.
Exhibit 31.1

CERTIFICATION

I, Arthur D. Sams,
certify that:



1. I have reviewed
this Annual Report on Form 10-K of Polar Power, Inc.;



2. Based on my knowledge,
this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by
this report;



3. Based on my knowledge,
the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;



4. The registrant’s
other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



(a) Designed such
disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;



(b) Evaluated the
effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and



(c) Disclosed in
this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s
most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and



5. The registrant’s
other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting,
to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing
the equivalent functions):



(a) All significant
deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and



(b) Any fraud, whether
or not material, that involves management or other employees who have a significant role in the registrant’s internal control
over financial reporting.



Date:
March 9, 2017



|/s/ ARTHUR D. SAMS                    |  | 
|------------------------------------- |  | 
|Arthur D. Sams                        |  | 
|President and Chief Executive Officer |  | 
|(Principal Executive Officer)         |  |
IN THE DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FIFTH DISTRICT

NOT FINAL UNTIL TIME EXPIRES TO

FILE MOTION FOR REHEARING AND

DISPOSITION THEREOF IF FILED

JAMARIAN MORELAND, 

Appellant, 

v. Case No. 5D21-2245

LT Case No. 05-2017-CF-029876-D

STATE OF FLORIDA, 

 Appellee. 

________________________________/ 

Decision filed July 5, 2022

Appeal from the Circuit Court 

for Brevard County, 

David C. Koenig, Judge. 

Matthew J. Metz, Public Defender, and 

Glendon G. Gordon, Jr., Assistant Public 

Defender, Daytona Beach, for Appellant. 

Ashley Moody, Attorney General, 

Tallahassee, and Roberts J. Bradford, 

Jr., Assistant Attorney General, Daytona 

Beach, for Appellee. 

PER CURIAM. 

AFFIRMED. 

EVANDER, NARDELLA and WOZNIAK, JJ., concur.
# C_2015302EN.01002401.xml

| 14.9.2015 | EN | Official Journal of the European Union | C 302/24 |
| --- | --- | --- | --- |

14.9.2015

EN

Official Journal of the European Union

C 302/24

---

Request for a preliminary ruling from the Corte di Appello di Bari (Italy) lodged on 13 July 2015 — Leonmobili Srl, Gennaro Leone v Homag Holzbearbeitungssysteme GmbH and Others

(Case C-353/15)

(2015/C 302/30)

Language of the case: Italian

Referring court

Referring court

Corte di Appello di Bari

Parties to the main proceedings

Parties to the main proceedings

Applicants: Leonmobili Srl, Gennaro Leone

Applicants:

Defendants: Homag Holzbearbeitungssysteme GmbH, Curatela del Fallimento Leonmobili Srl, ICO Srl, Arturo Salice SpA, Grafiche Ricciarelli di Ricciarelli Bernardino, Deutsche Bank SpA, Fida Srl, Elica SpA

Defendants:

Questions referred

Questions referred

| a) | In the absence of any establishment in another Member State may the presumption provided for by the last part of Article 3(1) and Article 3(2) of Council Regulation (EC) No 1346/2000 (1) be rebutted in a challenge to jurisdiction by evidence that the centre of main interests of a company is in a different State from the one where the company has its registered office. |
| --- | --- |

a)

In the absence of any establishment in another Member State may the presumption provided for by the last part of Article 3(1) and Article 3(2) of Council Regulation (EC) No 1346/2000 (1) be rebutted in a challenge to jurisdiction by evidence that the centre of main interests of a company is in a different State from the one where the company has its registered office.

1

| b) | If the answer to the preceding question is in the affirmative, may that evidence be derived from another presumption, that is to say, from the assessment of information from which it can be logically deduced that the centre of main interests is in another Member State. |
| --- | --- |

b)

If the answer to the preceding question is in the affirmative, may that evidence be derived from another presumption, that is to say, from the assessment of information from which it can be logically deduced that the centre of main interests is in another Member State.

---

(1)  Council Regulation (EC) No 1346/2000 of 29 May 2000 on insolvency proceedings (OJ 2000 L 160, p. 1).

1

---
EXHIBIT 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION
                      906 OF THE SARBANES-OXLEY ACT OF 2002


Each of the undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as
adopted  pursuant  to  Section  906 of the Sarbanes-Oxley Act of 2002, that this
Quarterly  Report  on Form 10-QSB for the quarter ended September 30, 2003 fully
complies  with  the  requirements  of  Section  13(a) or 15(d) of the Securities
Exchange  Act  of 1934, as amended, and the information contained in such report
fairly  presents,  in all material respects, the financial condition and results
of  operations  of  the  Company.

This  7th  day  of  November,  2003.


/s/  Robert  G.  Peck
---------------------
President  and  Chief  Executive  Officer
(Principal  Executive  Officer)

/s/  Harle  B.  Green
---------------------
Chief  Financial  Officer
(Principal  Financial  Officer)


<PAGE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Energy

###### Federal Energy Regulatory Commission

          - [Docket No. EL21-9-000]

On March 7, 2022, North Carolina Electric Membership Corporation (NCEMC) filed a motion to continue to hold the complaint filed in the above-captioned proceeding in abeyance until June 1, 2022. NCEMC represents that itself and Duke Energy Progress, LLC (DEP) have been negotiating an agreement to implement several changes to the Power Supply and Coordination Agreement at issue in this proceeding, but the parties need additional time to finalize the agreement. NCEMC asks that the Commission delay taking any action in this docket for an additional period up to and including June 1, 2022, to allow parties to continue to finalize these details. NCEMC also states that DEP supports the motion.

Upon consideration, notice is hereby given that NCEMC's motion is granted. As such, the Commission will not take any action on the complaint filed in this proceeding until after June 1, 2022.

Dated: March 16, 2022.

Kimberly D. Bose,

Secretary.

[FR Doc. 2022-06015 Filed 3-21-22; 8:45 am]

BILLING CODE 6717-01-P
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Joint Board for the Enrollment of Actuaries

# AGENCY:

Joint Board for the Enrollment of Actuaries.

# ACTION:

Notice of federal advisory committee meeting.

# SUMMARY:

The Joint Board for the Enrollment of Actuaries gives notice of a closed teleconference meeting of the Advisory Committee on Actuarial Examinations.

# DATES:

The meeting will be held on April 22, 2022, from 9:00 a.m. to 5:00 p.m. (EDT).

# FOR FURTHER INFORMATION CONTACT:

                        Elizabeth Van Osten, Designated Federal Officer, Advisory Committee on Actuarial Examinations, at (202) 317-3648 or                         *elizabeth.j.vanosten@irs.gov.*

# SUPPLEMENTARY INFORMATION:

Notice is hereby given that the Advisory Committee on Actuarial Examinations will hold a teleconference meeting on April 22, 2022, from 9:00 a.m. to 5:00 p.m. (EDT). The meeting will be closed to the public.

The purpose of the meeting is to discuss topics and questions that may be recommended for inclusion on future Joint Board examinations in actuarial mathematics, pension law and methodology referred to in 29 U.S.C. 1242(a)(1)(B).

A determination has been made as required by section 10(d) of the Federal Advisory Committee Act, 5 U.S.C. app., that the subject of the meeting falls within the exception to the open meeting requirement set forth in Title 5 U.S.C. 552b(c)(9)(B), and that the public interest requires that such meeting be closed to public participation.

                    The Executive Director of the Joint Board for the Enrollment of Actuaries, having reviewed and approved this document, is delegating the authority to electronically sign this document to Susan L. Erdos, who is the                     **Federal Register**                     Liaison for the Joint Board for the Enrollment of Actuaries, for purposes of publication in the                     **Federal Register**                    .                

Dated: March 22, 2022.

Susan L. Erdos,

Federal Register Liaison, Joint Board for the Enrollment of Actuaries.

[FR Doc. 2022-06355 Filed 3-24-22; 8:45 am]

BILLING CODE 4830-01-P
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF LORAL SPACE & COMMUNICATIONS LTD. FOR THE NINE MONTHS
ENDED SEPTEMBER 30, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                         265,644
<SECURITIES>                                         0
<RECEIVABLES>                                  487,788
<ALLOWANCES>                                     3,837
<INVENTORY>                                    181,314
<CURRENT-ASSETS>                             1,179,656
<PP&E>                                       2,212,891
<DEPRECIATION>                               (282,345)
<TOTAL-ASSETS>                               5,734,886
<CURRENT-LIABILITIES>                          693,521
<BONDS>                                      1,986,818
<PREFERRED-MANDATORY>                              459
<PREFERRED>                                    736,704
<COMMON>                                         2,448
<OTHER-SE>                                   2,072,249
<TOTAL-LIABILITY-AND-EQUITY>                 5,734,886
<SALES>                                      1,031,515
<TOTAL-REVENUES>                             1,031,515
<CGS>                                          886,641
<TOTAL-COSTS>                                1,039,207
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              67,184
<INCOME-PRETAX>                               (15,651)
<INCOME-TAX>                                  (27,878)
<INCOME-CONTINUING>                           (89,033)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (123,852)
<EPS-BASIC>                                     (0.43)
<EPS-DILUTED>                                   (0.43)


</TABLE>
Exhibit



Exhibit 10.19



STOCK OPTION GRANT
 
 
Dear Arvind Agrawal (the “Option Holder”),
 
As per the Letter Agreement dated November 12, 2014 between Lightlake Therapeutics Inc. (the “Company”) and you, you have been granted options (the “Options”) to purchase common stock (the “Common Stock”) of the Company (with each share of Common Stock of the Company, a “Share”) as follows:
	
		
	 
	 

	 
	 

	Date of Grant:
	November 12, 2014

	 
	 

	Exercise Price per Share:
	US$0.15

	 
	 

	Total Number of Shares Granted:
	2,000,000

	 
	 

	Total Exercise Price:
	Cashless exercise

	 
	 

	Type of Options:
	Non-Qualified Stock Options

	 
	 

	Expiration Date:
	November 11, 2019

	 
	 

	Termination Period:
	These Options may be exercised for a period of five (5) years from the Date of Grant.  You are responsible for keeping track of this exercise period. The Company will not provide further notice of such period.

	 
	 

	Transferability:
	These Options may not be transferred, except as permitted by applicable laws and regulations.

	 
	 

	Restriction on Exercise:
	Your ability to exercise these Options is contingent on your and your officers, agents, and representatives keeping confidential information shared with you and your officers, agent, and representatives confidential and complying with all applicable laws and regulations.

	 
	 

	Vesting:
	166,666 at the end of each calendar quarter for each of the next 11 calendar quarters and 166,674 at the end of the subsequent calendar quarter.




 
 
Following receipt by the Company of evidence and/or an indemnity from you to the Company in a form reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of these Options or any certificates for representing the Shares underlying these Options and, in the event of mutilation, following the surrender and cancellation of such Options or stock certificate, the Company will make and deliver replacement Options or stock certificate of like tenor and dated as of such cancellation, in lieu of these Options or stock certificates, without any charge therefor, it being understood that the making and/or delivery of such replacement Options or stock certificates by the Company will not be unreasonably withheld.  Any such replacement Options or stock certificates shall be subject to the same terms, conditions, and restrictions as these Options and any Shares underlying these Options. Proportionate adjustments shall automatically be made to both the Exercise Price and number of these Options in the event of a stock split, 




Exhibit 10.19



recapitalization, change of control and fundamental transaction.  Upon the exercise of these Options, the fair market value per Share shall be equal to the closing price of the Shares on the day prior to such exercise.


By your signature and the signature of the Company’s representative below, you and the Company agree to the terms of these Options.
 
 
	
			
	 ARVIND AGRAWAL
	 
	LIGHTLAKE THERAPEUTICS INC.

	 
	 
	 

	/s/ Arvind Agrawal
	 
	 /s/ Kevin Pollack

	Optionee
	 
	Name: Kevin Pollack 
Title: Chief Financial Officer